A study of 1,068 adults found whole-blood NAD fell in those with cardiovascular disease and hypertension but did not decline with age.
News|Articles|June 24, 2024
7 Takeaways from CMS Projections for U.S. Healthcare Spending
Author(s)Logan Lutton, Peter Wehrwein, Managing Editor
The CMS released its projections earlier this month, saying healthcare spending will hit $7.7 trillion by 2032.
Advertisement
Earlier this month, the CMS Office of the Actuary released its annual
Here are some other takeaways from the projections by CMS analysts.
Advertisement
Related to this article
Adding Sunharbo (asundexian), a first-in-class Factor XI inhibitor, to single or dual antiplatelet therapy reduces ischemic stroke risk without increasing the risk of major bleeding.
In this discussion, University College London colleagues Joshua Stott, Ph.D., professor of aging and clinical psychology and research assistant Lucy Corrigan, who led the work while at the University of Liverpool, talk about their recent meta-analysis linking ADHD to a higher risk of death from all causes, including suicide, injury and natural causes.
The American Academy of Sleep Medicine’s first update since 2007 favors generic drugs, caffeine, light and naps, and advises against benzodiazepines.
People with advanced Parkinson’s disease who also have a sleep disorder cost about $50,000 a year to treat, $13,000 more than similar patients without one, according to an AbbVie-funded claims analysis.
Geisinger Health Plan President Jeremy Gaskill says the possibility that a growing number of patients won't have health insurance could put tremendous financial pressure on the plan's providers.
γδ T cells infiltrate small cell lung cancer tumors and can kill them without the MHC-I machinery these tumors typically switch off, and patients with more of them trended toward longer survival on anti-PD-L1 immunotherapy.
Upstream payment accuracy should reduce avoidable noise before it reaches those downstream functions.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
A new strategy for secondary stroke prevention gets boost from FDA approval
2
As psychedelic drugs near FDA decisions, people with HIV remain absent from trials, commentary says
3
A conversation with Joshua Stott, Ph.D., and Lucy Corrigan about the 70% higher mortality risk associated with ADHD
4
Sleep disorders add $13,000 a year to advanced Parkinson’s care costs
5